{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:57:52Z","timestamp":1773190672466,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00347-021-01415-3","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T09:03:22Z","timestamp":1620378202000},"page":"553-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pr\u00e4konditionierung von\u00a0vaskularisierten Hochrisikoaugen mittels Feinnadeldiathermie und Crosslinking","Preconditioning of vascularized high-risk eyes using fine-needle diathermy and cross-linking"],"prefix":"10.1007","volume":"118","author":[{"given":"M.","family":"Matthaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. N. H.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Siebelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Roters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. O.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000099253","volume":"92","author":"C Cursiefen","year":"2007","unstructured":"Cursiefen\u00a0C (2007) Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy 92:50\u201357","journal-title":"Chem Immunol Allergy"},{"key":"1415_CR2","doi-asserted-by":"publisher","first-page":"100768","DOI":"10.1016\/j.preteyeres.2019.07.001","volume":"73","author":"D Hos","year":"2019","unstructured":"Hos\u00a0D, Matthaei\u00a0M, Bock\u00a0F et\u00a0al (2019) Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res 73:100768","journal-title":"Prog Retin Eye Res"},{"key":"1415_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","volume":"34","author":"F Bock","year":"2013","unstructured":"Bock\u00a0F, Maruyama\u00a0K, Regenfuss\u00a0B et\u00a0al (2013) Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res 34:89\u2013124","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1415_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1755-3768.2011.02312.x","volume":"91","author":"B Bachmann","year":"2013","unstructured":"Bachmann\u00a0B, Taylor\u00a0RS, Cursiefen\u00a0C (2013) The association between corneal neovascularization and visual acuity: a\u00a0systematic review. Acta Ophthalmol 91(1):12\u201319","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1415_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","volume":"144","author":"NX Nguyen","year":"2007","unstructured":"Nguyen\u00a0NX, Seitz\u00a0B, Martus\u00a0P, Langenbucher\u00a0A, Cursiefen\u00a0C (2007) Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol 144(2):318\u2013319","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1415_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/archopht.1981.03930010599002","volume":"99","author":"OC Alldredge","year":"1981","unstructured":"Alldredge\u00a0OC, Krachmer\u00a0JH (1981) Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 99(4):599\u2013604","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"1415_CR7","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archopht.121.8.1087","volume":"121","author":"MO Price","year":"2003","unstructured":"Price\u00a0MO, Thompson\u00a0RW Jr., Price\u00a0FW Jr. (2003) Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol 121(8):1087\u20131092","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"1415_CR8","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.transproceed.2007.08.020","volume":"39","author":"D Sellami","year":"2007","unstructured":"Sellami\u00a0D, Abid\u00a0S, Bouaouaja\u00a0G et\u00a0al (2007) Epidemiology and risk factors for corneal graft rejection. Transplant Proc 39(8):2609\u20132611","journal-title":"Transplant Proc"},{"issue":"5","key":"1415_CR9","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1097\/TXD.0000000000000894","volume":"5","author":"D Hos","year":"2019","unstructured":"Hos\u00a0D, Le\u00a0VNH, Hellmich\u00a0M et al (2019) Risk of corneal graft rejection after high-risk keratoplasty following fine-needle vessel coagulation of corneal neovascularization combined with Bevacizumab: a pilot study. Transplant Direct 5(5):e452","journal-title":"Transplant Direct"},{"issue":"7","key":"1415_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","volume":"117","author":"B Bachmann","year":"2010","unstructured":"Bachmann\u00a0B, Taylor\u00a0RS, Cursiefen\u00a0C (2010) Corneal neovascularization as a\u00a0risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology 117(7):1300\u20131305e7","journal-title":"Ophthalmology"},{"issue":"4","key":"1415_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/01.ico.0000183485.85636.ff","volume":"25","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen\u00a0C, Maruyama\u00a0K, Jackson\u00a0DG, Streilein\u00a0JW, Kruse\u00a0FE (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25(4):443\u2013447","journal-title":"Cornea"},{"issue":"7","key":"1415_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s004170100313","volume":"239","author":"C Cursiefen","year":"2001","unstructured":"Cursiefen\u00a0C, Wenkel\u00a0H, Martus\u00a0P et al (2001) Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 239(7):514\u2013521","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1415_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.survophthal.2007.12.005","volume":"53","author":"MA Cunningham","year":"2008","unstructured":"Cunningham\u00a0MA, Edelman\u00a0JL, Kaushal\u00a0S (2008) Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol 53(2):139\u2013149","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"1415_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","volume":"16","author":"D Roshandel","year":"2018","unstructured":"Roshandel\u00a0D, Eslani\u00a0M, Baradaran-Rafii\u00a0A et al (2018) Current and emerging therapies for corneal neovascularization. Ocul Surf 16(4):398\u2013414","journal-title":"Ocul Surf"},{"issue":"8","key":"1415_CR15","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen\u00a0C, Cao\u00a0J, Chen\u00a0L et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Investig Ophthalmol Vis Sci 45(8):2666\u20132673","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"1415_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archopht.126.1.71","volume":"126","author":"BO Bachmann","year":"2008","unstructured":"Bachmann\u00a0BO, Bock\u00a0F, Wiegand\u00a0SJ et al (2008) Promotion of graft survival by vascular endothelial growth factor a\u00a0neutralization after high-risk corneal transplantation. Arch Ophthalmol 126(1):71\u201377","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"1415_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1136\/bjo.2008.145128","volume":"93","author":"BO Bachmann","year":"2009","unstructured":"Bachmann\u00a0BO, Luetjen-Drecoll\u00a0E, Bock\u00a0F et al (2009) Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol 93(8):1075\u20131080","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1415_CR18","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","volume":"116","author":"C Cursiefen","year":"2009","unstructured":"Cursiefen\u00a0C, Bock\u00a0F, Horn\u00a0FK et al (2009) GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a\u00a0randomized phase II trial. Ophthalmology 116(9):1630\u20131637","journal-title":"Ophthalmology"},{"issue":"9","key":"1415_CR19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","volume":"121","author":"C Cursiefen","year":"2014","unstructured":"Cursiefen\u00a0C, Viaud\u00a0E, Bock\u00a0F et al (2014) Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I\u2011CAN study. Ophthalmology 121(9):1683\u20131692","journal-title":"Ophthalmology"},{"issue":"2","key":"1415_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"F Bock","year":"2008","unstructured":"Bock\u00a0F, Konig\u00a0Y, Kruse\u00a0F, Baier\u00a0M, Cursiefen\u00a0C (2008) Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 246(2):281\u2013284","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"1415_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/archopht.1967.00980020639013","volume":"77","author":"W Mayer","year":"1967","unstructured":"Mayer\u00a0W (1967) Cryotherapy in corneal vascularization. Arch Ophthalmol 77(5):637\u2013641","journal-title":"Arch Ophthalmol"},{"key":"1415_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0161-6420(92)31996-7","volume":"99(2","author":"JC Baer","year":"1992","unstructured":"Baer\u00a0JC, Foster\u00a0CS (1992) Corneal laser photocoagulation for treatment of neovascularization. Efficacy of 577\u202fnm yellow dye laser. Ophthalmology 99(2:173\u2013179","journal-title":"Ophthalmology"},{"issue":"8","key":"1415_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","volume":"31","author":"Y Koenig","year":"2012","unstructured":"Koenig\u00a0Y, Bock\u00a0F, Kruse\u00a0FE, Stock\u00a0K, Cursiefen\u00a0C (2012) Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea 31(8):887\u2013892","journal-title":"Cornea"},{"issue":"8","key":"1415_CR24","first-page":"2148","volume":"41","author":"CT Pillai","year":"2000","unstructured":"Pillai\u00a0CT, Dua\u00a0HS, Hossain\u00a0P (2000) Fine needle diathermy occlusion of corneal vessels. Investig Ophthalmol Vis Sci 41(8):2148\u20132153","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"1415_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2015.02.012","volume":"122","author":"N Spiteri","year":"2015","unstructured":"Spiteri\u00a0N, Romano\u00a0V, Zheng\u00a0Y et al (2015) Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization. Ophthalmology 122(6):1079\u20131084","journal-title":"Ophthalmology"},{"issue":"1","key":"1415_CR26","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1038\/s41598-020-60705-z","volume":"10","author":"VNH Le","year":"2020","unstructured":"Le\u00a0VNH, Hou\u00a0Y, Bock\u00a0F, Cursiefen\u00a0C (2020) Supplemental anti vegf A\u2011therapy prevents rebound neovascularisation after fine needle diathermy treatment to regress pathological corneal (LYMPH)Angiogenesis. Sci Rep 10(1):3908","journal-title":"Sci Rep"},{"issue":"4","key":"1415_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/bjophthalmol-2013-303729","volume":"98","author":"S Trikha","year":"2014","unstructured":"Trikha\u00a0S, Parikh\u00a0S, Osmond\u00a0C, Anderson\u00a0DF, Hossain\u00a0PN (2014) Long-term outcomes of Fine Needle Diathermy for established corneal neovascularisation. Br J Ophthalmol 98(4):454\u2013458","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1415_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/ICO.0000000000000865","volume":"35","author":"V Romano","year":"2016","unstructured":"Romano\u00a0V, Steger\u00a0B, Brunner\u00a0M, Ahmad\u00a0S, Willoughby\u00a0CE, Kaye\u00a0SB (2016) Method for angiographically guided fine-needle diathermy in the treatment of corneal neovascularization. Cornea 35(7):1029\u20131032","journal-title":"Cornea"},{"issue":"1","key":"1415_CR29","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1038\/s41598-018-24037-3","volume":"8","author":"VNH Le","year":"2018","unstructured":"Le\u00a0VNH, Schneider\u00a0AC, Scholz\u00a0R, Bock\u00a0F, Cursiefen\u00a0C (2018) Fine needle-diathermy regresses pathological corneal (lymph)angiogenesis and promotes high-risk corneal transplant survival. Sci Rep 8(1):5707","journal-title":"Sci Rep"},{"key":"1415_CR30","unstructured":"Williams KA, Keane MC, Galettis RA, Jones VJ, Mills RAD, Coster DJ (2015) The Australian corneal graft registry. https:\/\/researchnow-admin.flinders.edu.au\/ws\/portalfiles\/portal\/16917342\/ACGR_report_2015_2.pdf. Zugegriffen: 9. Jan. 2021"},{"issue":"1","key":"1415_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exer.1997.0410","volume":"66","author":"E Spoerl","year":"1998","unstructured":"Spoerl\u00a0E, Huhle\u00a0M, Seiler\u00a0T (1998) Induction of cross-links in corneal tissue. Exp Eye Res 66(1):97\u2013103","journal-title":"Exp Eye Res"},{"issue":"1","key":"1415_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00347-002-0700-3","volume":"100","author":"G Wollensak","year":"2003","unstructured":"Wollensak\u00a0G, Sporl\u00a0E, Seiler\u00a0T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100(1):44\u201349","journal-title":"Ophthalmologe"},{"issue":"2","key":"1415_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00347-008-1790-3","volume":"106","author":"C Cursiefen","year":"2009","unstructured":"Cursiefen\u00a0C (2009) Corneal crosslinking: \u201cSafe and effective\u201d? Ophthalmologe 106(2):164\u2013165 (author reply 165-166.)","journal-title":"Ophthalmologe"},{"issue":"8","key":"1415_CR34","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.ophtha.2013.01.012","volume":"120","author":"H Hashemi","year":"2013","unstructured":"Hashemi\u00a0H, Seyedian\u00a0MA, Miraftab\u00a0M, Fotouhi\u00a0A, Asgari\u00a0S (2013) Corneal collagen cross-linking with riboflavin and ultraviolet a\u00a0irradiation for keratoconus: long-term results. Ophthalmology 120(8):1515\u20131520","journal-title":"Ophthalmology"},{"issue":"4","key":"1415_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3928\/1081597X-20200226-02","volume":"36","author":"B Knyazer","year":"2020","unstructured":"Knyazer\u00a0B, Krakauer\u00a0Y, Tailakh\u00a0MA et al (2020) Accelerated corneal cross-linking as an adjunct therapy in the management of presumed bacterial keratitis: a cohort study. J\u00a0Refract Surg 36(4):258\u2013264","journal-title":"J Refract Surg"},{"issue":"6","key":"1415_CR36","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1055\/s-0034-1368535","volume":"231","author":"C Ammermann","year":"2014","unstructured":"Ammermann\u00a0C, Cursiefen\u00a0C, Hermann\u00a0M (2014) Corneal cross-linking in microbial keratitis to prevent a\u00a0chaud keratoplasty: a\u00a0retrospective case series. Klin Monbl Augenheilkd 231(6):619\u2013625","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"1415_CR37","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/ICO.0000000000000830","volume":"35","author":"G Toth","year":"2016","unstructured":"Toth\u00a0G, Bucher\u00a0F, Siebelmann\u00a0S et al (2016) In situ corneal cross-linking for recurrent corneal melting after boston type 1 keratoprosthesis. Cornea 35(6):884\u2013887","journal-title":"Cornea"},{"issue":"12","key":"1415_CR38","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1111\/ajt.14874","volume":"18","author":"Y Hou","year":"2018","unstructured":"Hou\u00a0Y, Le\u00a0VNH, Toth\u00a0G et al (2018) UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival. Am J Transplant 18(12):2873\u20132884","journal-title":"Am J Transplant"},{"issue":"2","key":"1415_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ICO.0000000000002406","volume":"40","author":"F Schaub","year":"2021","unstructured":"Schaub\u00a0F, Hou\u00a0Y, Zhang\u00a0W, Bock\u00a0F, Hos\u00a0D, Cursiefen\u00a0C (2021) Corneal crosslinking to regress pathologic corneal neovascularization before high-risk keratoplasty. Cornea 40(2):147\u2013155","journal-title":"Cornea"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01415-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01415-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T17:19:06Z","timestamp":1623172746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01415-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01415-3","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"assertion":[{"value":"30 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Matthaei, D.\u00a0Hos, F.\u00a0Bock, V.N.H.\u00a0Le, Y.\u00a0Hou, F.\u00a0Schaub, S.\u00a0Siebelmann, W.\u00a0Zhang, S.\u00a0Roters, B.O.\u00a0Bachmann und C.\u00a0Cursiefen geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}